{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:23:46Z","timestamp":1782843826425,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Liaoning Province, China","award":["2020-BS-116"],"award-info":[{"award-number":["2020-BS-116"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Henoch-Sch\u00f6nlein purpura (HSP), also called IgA vasculitis, is a systemic vasculitis characterized by deposits of immunoglobulin A in blood vessels. Renal impairment of these patients is the main determinant of prognosis. The optimal treatment of HSP nephritis (HSPN) in children remains controversial, but many clinicians administer an immunosuppressive agent with a corticosteroid. A previous study reported that leflunomide (LEF) with a corticosteroid was effective for adult patients with HSPN and nephrotic proteinuria. However, data on this treatment in pediatric patients is limited.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We described our experience at a single center on the use of LEF in 5 pediatric patients who had IgA vasculitis with proteinuria that was nearly 50\u00a0mg\/kg (nephrotic range) and remained high despite administration of intravenous steroid, and biopsy-proven nephritis. All patients had class II to IIIb lesions based on the International Study of Kidney Disease in Children (ISKDC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We successfully treated all 5 children who had IgA vasculitis with nephritis using LEF with a corticosteroid. Four patients achieved a complete remission of proteinuria, and 1 patient had significantly reduced proteinuria. The children received LEF for 6 months to 12 months, and none of them had severe adverse events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>To our knowledge, this is the first case series to report successful treatment of pediatric HSPN with LEF in combination with a corticosteroid.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-021-02866-y","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T06:02:43Z","timestamp":1631080963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Leflunomide therapy for IgA vasculitis with nephritis in children"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2596-9953","authenticated-orcid":false,"given":"Ling","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5603-4475","authenticated-orcid":false,"given":"Zhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1095-1120","authenticated-orcid":false,"given":"Yue","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"issue":"1","key":"2866_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12969-019-0311-z","volume":"17","author":"M Jelusic","year":"2019","unstructured":"Jelusic M, Sestan M, Cimaz R, Ozen S. Different histological classifications for Henoch-Schonlein purpura nephritis: which one should be used? Pediatr Rheumatol Online J. 2019;17(1):10. https:\/\/doi.org\/10.1186\/s12969-019-0311-z.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"7","key":"2866_CR2","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/ard.2005.046300","volume":"65","author":"S Ozen","year":"2006","unstructured":"Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR\/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936\u201341. https:\/\/doi.org\/10.1136\/ard.2005.046300.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2866_CR3","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jpc.12403","volume":"49","author":"P Trnka","year":"2013","unstructured":"Trnka P. Henoch-Schonlein purpura in children. J Paediatr Child Health. 2013;49(12):995\u20131003. https:\/\/doi.org\/10.1111\/jpc.12403.","journal-title":"J Paediatr Child Health"},{"issue":"8","key":"2866_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1212\/wnl.0000000000001280","volume":"84","author":"GK Bergey","year":"2015","unstructured":"Bergey GK, Morrell MJ, Mizrahi EM, Goldman A, King-Stephens D, Nair D, et al. Long-term treatment with responsive brain stimulation in adults with refractory partial seizures. Neurology. 2015;84(8):810\u20137. https:\/\/doi.org\/10.1212\/wnl.0000000000001280.","journal-title":"Neurology"},{"issue":"10","key":"2866_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrneph.2014.126","volume":"10","author":"JC Davin","year":"2014","unstructured":"Davin JC, Coppo R. Henoch-Sch\u00f6nlein purpura nephritis in children. Nat Rev Nephrol. 2014;10(10):563\u201373. https:\/\/doi.org\/10.1038\/nrneph.2014.126.","journal-title":". Nat Rev Nephrol"},{"issue":"6","key":"2866_CR6","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1046\/j.1523-1755.1998.00915.x","volume":"53","author":"Y Kaku","year":"1998","unstructured":"Kaku Y, Nohara K, Honda S. Renal involvement in Henoch-Schonlein purpura: a multivariate analysis of prognostic factors. Kidney Int. 1998;53(6):1755\u20139. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00915.x.","journal-title":". Kidney Int"},{"issue":"6","key":"2866_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00467-011-1827-8","volume":"26","author":"H Wakaki","year":"2011","unstructured":"Wakaki H, Ishikura K, Hataya H, Hamasaki Y, Sakai T, Yata N, et al. Henoch-Schonlein purpura nephritis with nephrotic state in children: predictors of poor outcomes. Pediatr Nephrol. 2011;26(6):921\u20135. https:\/\/doi.org\/10.1007\/s00467-011-1827-8.","journal-title":"Pediatr Nephrol"},{"key":"2866_CR8","doi-asserted-by":"publisher","unstructured":"Hahn D, Hodson EM, Willis NS, Craig JC. Interventions for preventing and treating kidney disease in Henoch-Sch\u00f6nlein Purpura (HSP). Cochrane Database Syst Rev. 2015(8):CD005128. https:\/\/doi.org\/10.1002\/14651858.CD005128.pub3.","DOI":"10.1002\/14651858.CD005128.pub3"},{"issue":"9","key":"2866_CR9","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/rheumatology\/kez041","volume":"58","author":"S Ozen","year":"2019","unstructured":"Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T, et al. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford). 2019;58(9):1607\u201316. https:\/\/doi.org\/10.1093\/rheumatology\/kez041.","journal-title":"Rheumatology (Oxford)"},{"key":"2866_CR10","doi-asserted-by":"publisher","unstructured":"Chapter 11: Henoch-Schonlein purpura nephritis. Kidney Int Suppl (2011). 2012;2(2):218\u201320. https:\/\/doi.org\/10.1038\/kisup.2012.24.","DOI":"10.1038\/kisup.2012.24"},{"issue":"5","key":"2866_CR11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00467-011-2057-9","volume":"27","author":"Y Du","year":"2012","unstructured":"Du Y, Hou L, Zhao C, Han M, Wu Y. Treatment of children with Henoch-Schonlein purpura nephritis with mycophenolate mofetil. Pediatr Nephrol. 2012;27(5):765\u201371. https:\/\/doi.org\/10.1007\/s00467-011-2057-9.","journal-title":". Pediatr Nephrol"},{"issue":"3","key":"2866_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00467-010-1723-7","volume":"26","author":"JM Park","year":"2011","unstructured":"Park JM, Won SC, Shin JI, Yim H, Pai KS. Cyclosporin A therapy for Henoch-Schonlein nephritis with nephrotic-range proteinuria. Pediatr Nephrol. 2011;26(3):411\u20137. https:\/\/doi.org\/10.1007\/s00467-010-1723-7.","journal-title":". Pediatr Nephrol"},{"issue":"1","key":"2866_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s42358-019-0064-x","volume":"59","author":"V Schinzel","year":"2019","unstructured":"Schinzel V, Fernandez JD, Clemente G, Fraga MM, Andrade MC, Len CA, et al. The profile and clinical outcomes of patients with renal involvement due to IgA vasculitis: is azathioprine a good option for treatment? Adv Rheumatol. 2019;59(1):21. https:\/\/doi.org\/10.1186\/s42358-019-0064-x.","journal-title":"Adv Rheumatol"},{"issue":"7","key":"2866_CR14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1177\/0961203308089408","volume":"17","author":"HY Wang","year":"2008","unstructured":"Wang HY, Cui TG, Hou FF, Ni ZH, Chen XM, Lu FM, et al. Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study. Lupus. 2008;17(7):638\u201344. https:\/\/doi.org\/10.1177\/0961203308089408.","journal-title":"Lupus"},{"issue":"2","key":"2866_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1440-1797.2006.00547.x","volume":"11","author":"T Lou","year":"2006","unstructured":"Lou T, Wang C, Chen Z, Shi C, Tang H, Liu X, et al. Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy. Nephrology (Carlton). 2006;11(2):113\u20136. https:\/\/doi.org\/10.1111\/j.1440-1797.2006.00547.x.","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"2866_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/nep.12175","volume":"19","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Gao Y, Zhang Z, Liu G, He H, Liu L. Leflunomide in addition to steroids improves proteinuria and renal function in adult Henoch-Schoenlein nephritis with nephrotic proteinuria. Nephrology (Carlton). 2014;19(2):94\u2013100. https:\/\/doi.org\/10.1111\/nep.12175.","journal-title":". Nephrology (Carlton)"},{"issue":"5","key":"2866_CR17","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/ard.2009.116657","volume":"69","author":"S Ozen","year":"2010","unstructured":"Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR\/PRINTO\/PRES criteria for Henoch-Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010;69(5):798\u2013806. https:\/\/doi.org\/10.1136\/ard.2009.116657.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2866_CR18","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s00467-008-1066-9","volume":"24","author":"M Zaffanello","year":"2009","unstructured":"Zaffanello M, Fanos V. Treatment-based literature of Henoch-Sch\u00f6nlein purpura nephritis in childhood. Pediatr Nephrol. 2009;24(10):1901\u201311. https:\/\/doi.org\/10.1007\/s00467-008-1066-9.","journal-title":". Pediatr Nephrol"},{"key":"2866_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.fct.2018.06.054","volume":"118","author":"Q Wu","year":"2018","unstructured":"Wu Q, Wang X, Nepovimova E, Wang Y, Yang H, Kuca K. Mechanism of cyclosporine A nephrotoxicity: Oxidative stress, autophagy, and signalings. Food Chem Toxicol. 2018;118:889\u2013907. https:\/\/doi.org\/10.1016\/j.fct.2018.06.054.","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"2866_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12969-018-0285-2","volume":"16","author":"CB Crayne","year":"2018","unstructured":"Crayne CB, Eloseily E, Mannion ML, Azerf SP, Weiser P, Beukelman T, et al. Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature. Pediatr Rheumatol Online J. 2018;16(1):71. https:\/\/doi.org\/10.1186\/s12969-018-0285-2.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"2866_CR21","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/archdischild-2017-313788","volume":"103","author":"DF Zhang","year":"2018","unstructured":"Zhang DF, Hao GX, Li CZ, Yang YJ, Liu FJ, Liu L, et al. Off-label use of tacrolimus in children with Henoch-Schonlein purpura nephritis: a pilot study. Arch Dis Child. 2018;103(8):772\u20135. https:\/\/doi.org\/10.1136\/archdischild-2017-313788.","journal-title":"Arch Dis Child"},{"issue":"4","key":"2866_CR22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00007890-199602270-00020","volume":"61","author":"KF Siemasko","year":"1996","unstructured":"Siemasko KF, Chong AS, Williams JW, Bremer EG, Finnegan A. Regulation of B cell function by the immunosuppressive agent leflunomide. Transplantation. 1996;61(4):635\u201342. https:\/\/doi.org\/10.1097\/00007890-199602270-00020.","journal-title":". Transplantation"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02866-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-021-02866-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02866-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T06:05:21Z","timestamp":1631081121000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-021-02866-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2866"],"URL":"https:\/\/doi.org\/10.1186\/s12887-021-02866-y","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"assertion":[{"value":"1 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the research ethics board of Shengjing Hospital of China Medical University (2016PS41J), all methods were carried out in accordance with relevant guidelines and regulations. Informed consents were obtained from the patients parents\/legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients parents\/legal guardian for publication of this study and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"391"}}